Drugs / ASP-1001
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT00791102 Comparator | Jan → Sep 2010 | allergic rhinitis | University of Chicago | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ASP-1001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00791102 ↗ |
| Route | Intranasal | “when given as a nasal spray” NCT00791102 ↗ |